FindTrial
Sign In

streptozocin

DRUG5 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Emory University, Cambridge University Hospitals NHS Foundation Trust, H. Lee Moffitt Cancer Center and Research Institute, Gustave Roussy, Cancer Campus, Grand Paris

Conditions

Anaplastic AstrocytomaAnaplastic OligodendrogliomaColorectal CancerGastrointestinal Carcinoid TumorGlioblastoma MultiformeIslet Cell TumorMixed GliomasPancreatic Cancer

Phase 1

Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
CompletedNCT00003543
Memorial Sloan Kettering Cancer CenterColorectal Cancer
Start: 1998-06-30End: 2002-08-31Target: 18Updated: 2013-06-27

Phase 2

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
CompletedNCT00004688
Emory UniversityAnaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme +2
Start: 1996-08-31End: 1998-07-31Target: 35Updated: 2015-03-25
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
CompletedNCT00602082
Cambridge University Hospitals NHS Foundation TrustGastrointestinal Carcinoid Tumor, Islet Cell Tumor
Start: 2005-08-31End: 2009-12-31Target: 84Updated: 2013-08-07
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
TerminatedNCT00609765
H. Lee Moffitt Cancer Center and Research InstitutePancreatic Cancer
Start: 2007-08-31End: 2008-03-31Updated: 2017-03-23
Two Chemotherapy Regimens Plus or Minus Bevacizumab
Active, not recruitingNCT03351296
Gustave Roussy, Cancer Campus, Grand ParisPancreatic Cancer
Start: 2018-06-26End: 2028-12-31Updated: 2024-05-08